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To the Editor: Laryngeal carcinoma is one of the 10 most 
common tumours occurring in South African men.1 Our 
objective was to compile a profile of patients presenting with 
laryngeal carcinoma at Universitas Hospital in Bloemfontein, 
and to determine the time interval between the onset of 
symptoms and presentation. Patients with laryngeal carcinoma 
presented at a late stage. Hoarseness was the most common 
presenting symptom, but patients and medical personnel alike 
did not realise the significance of this symptom. A laryngeal 
cancer awareness campaign needs to be initiated to increase 
patient and health care workers’ awareness of the disease.
Patients and methods
Fifty consecutive patients with newly diagnosed laryngeal 
carcinoma, seen at the ENT clinic at Universitas Hospital 
between January 2005 and December 2006, were interviewed 
by one of the authors after obtaining written consent. Approval 
to conduct the study was obtained from the Ethics Committee 
of the Faculty of Health Sciences, University of the Free State.
   The following delays in referral were calculated:
•  patient delay – the interval between the patient noticing 
symptoms and presenting to a general practitioner (GP) or 
clinic
•  professional delay – the interval between the first 
presentation to a GP or clinic and consultation at the ENT 
clinic
•  total delay – the sum of the patient and professional delays.
Patients referred to the ENT clinic with symptoms of 
laryngeal carcinoma were seen within 1 week, so this delay 
was not included in the calculations.
The tumour site was recorded as the area where we felt that 
the tumour originated. The TNM classification system was 
used for tumour staging.2
Exclusion criteria were: previous laryngeal carcinoma, 
treatment started prior to referral, primary tumour site outside 
the larynx, histology other than squamous carcinoma and 
patient refusal to participate in the study.
Results
The ages of the patients ranged between 41 and 87 years with a 
mean age of 61.9 (SD 9.6 years). Forty-four (88%) patients were 
male, while 6 (12%) were female. Black patients comprised 
80%, white patients 8% and coloured patients 12% of the 
cohort. The median ages were: black patients 61.4 years, white 
patients 68.5 years and coloured patients 60.0 years. Forty-eight 
(96%) patients were current or previous smokers while two 
had never smoked. Most patients (90%) had smoked cigarettes, 
while 6 (12%) had smoked a pipe. Snuff was used by 4 (8%) 
patients. Forty-five patients (90%) were alcohol consumers.
The presenting symptoms are outlined in Table I. Hoarseness 
(98%) was the most common symptom, followed by airway 
obstruction (64%) and odynophagia (62%). Hoarseness was 
present for a median of 5 months before referral.
The median patient delay was 1.5 months, the median 
professional delay 5 months and the median total delay 7 
months. 
The glottis (36%) and supraglottis (34%) were the most 
common sites of tumour origin, while 1 (2%) patient had a 
subglottic tumour. In 14 (28%) patients, the site of tumour 
origin could not be determined.
Most tumours were staged as T3 or T4 (Table II). However, 
the neck was staged as N0 in 64% of patients. Distant 
metastases were found in 4 patients. Eighty per cent of patients 
had late stage (stage 3 or 4) tumours, while only 20% had early 
stage laryngeal carcinoma (stage 1 or 2). 
Discussion
Few studies have been performed in Africa to compile a profile 
of patients presenting with laryngeal carcinoma.
The mean age of 61.9 years in our study group is similar 
to results found in European countries.3,4 The average age 
of patients diagnosed with laryngeal cancer in Nigeria was 
47 years.5 Twelve per cent of patients were female, all of 
whom had previously smoked. In European studies, females 
constituted 7 - 23.5% of patients. In African studies, the 
percentage of female patients with laryngeal cancer was 4% in 
Zimbabwe and 11% in Nigeria.3-7 
Hoarseness is the most common presenting symptom of 
laryngeal cancer.3,5-7 Brouha et al. reported that 96% of their 
patients with glottic tumours and 44% of patients with 
supraglottic tumours presented with hoarseness.6
A distressing factor in our study was the number of patients 
who presented with airway obstruction. These patients took 
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a median of 1 month to be referred. In Zimbabwe, 20% of 
patients were initially treated for severe asthma.7
Most tumours in our series were late stage. Tumushime-
Buturo et al. noted that most of their tumours were T3.7 Results 
in the Netherlands, where 92% of patients were diagnosed with 
early cancers, contrast dramatically with our study. This creates 
an enormous differential in prognosis, attributable to the easy 
access that patients in the Netherlands have to medical care.6
The patient delay of 1.5 months in our study compares very 
favourably with other studies, but the professional delay of a 
median of 5 months is high compared with European studies.3,4 
Brouha et al. found that the delay in referral of glottic tumours 
was more than double that of supraglottic tumours and 
attributed this to the fact that most GPs felt confident to treat 
a simple symptom such as hoarseness, but were more wary 
when hoarseness was accompanied by other symptoms such as 
dysphagia and odynophagia.6
Various factors play a role in diagnostic delay. In our 
study, patient ignorance seemed to be less important than 
professional delay. Brouha found that only 10% of patients 
with laryngeal cancer attributed their symptoms to smoking, 
while only 3.4% thought that cancer might be causing their 
symptoms.6 The latter study was conducted in the Netherlands; 
one would expect patient awareness of cancer to be even less in 
Third-World countries.
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Table I. Clinical symptoms
           Median duration of  
           symptoms until seen at  
Symptom       Present at interview Initial symptom complex Initial symptom alone ENT clinic (months)
Hoarseness              49 (98%)              35 (70%)             19 (38%)   5
Cough               27 (54%)              14 (28%)            4 (8%)   4
Dysphagia              29 (58%)              4 (8%)      2
Odynophagia              31 (62%)              12 (24%)            1 (2%)   3
Airway obstruction              32 (64%)              6 (12%)            1 (2%)   1
Haemoptysis              6 (12%)              1 (2%)      2
Neck mass              13 (26%)              8 (16%)            3 (6%)   4
Pain over larynx              3 (6%)              3 (6%)            0 (0%)   5
Otalgia               2 (4%)              0 (0%)            0 (0%)   5
Table II. Tumour staging
TNM   Patients (N=50) (%)
T1             4 (8%)
T2             7 (14%)
T3           25 (50%)
T4           14 (28%)
N0           32 (64%)
N1             7 (14%)
N2             2 (4%)
N3             9 (18%)
M0           46 (92%)
M1             4 (8%)
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